Tax Insights

Your Guide to State, Local, Federal, Estate + International Taxation

IRS expands list of preventive care allowed with High Deductible Health Plans

The IRS recently released Notice 2019-45 which expands the list of preventive care allowed with health savings accounts (HSAs). This notice focuses on treatment and testing for individuals diagnosed with certain chronic conditions, making care and prevention more affordable to taxpayers with high deductible health care plans.

Created in 2003, HSAs have become an increasingly popular tool available to the public for saving tax-free dollars to be used for medical expenses. Single individuals can contribute up to $3,500 before tax and families $7,000 in 2019. A great tax-saving tool, these accounts rollover automatically every year and grow tax-free over time.

You might think “what’s the catch?” Well for tax-preferred treatment of an HSA, the individual must also be covered by a high deductible health plan (HDHP). While having a high deductible might not sound ideal, the IRS does provide a safe harbor for certain medical care. Section 223 of the Internal Revenue Code notes a qualified plan “shall not fail to be treated as a high deductible health plan by reason of failing to have a deductible for preventive care.”

So what does that mean? And what is considered preventive care? Prior to 2019, this safe harbor generally meant taxpayers could see a health care professional for things like annual check-ups, immunizations, and various screenings with costs being covered by their HDHP. While this still holds true, the IRS’s most recent update now provides greater coverage to individuals diagnosed with or at risk to conditions such as diabetes, asthma, heart disease, etc. This is great news for taxpayers who were previously unable to afford care or were spending their own money.

Contact your friendly local CPA for more information on HSAs and HDHPs.

Preventive Care for Specified Conditions For Individuals Diagnosed with
Angiotensin Converting Enzyme (ACE) inhibitors Congestive heart failure, diabetes, and/or coronary artery disease
Antiresorptive therapy Osteoporosis and/or osteopenia
Beta-blockers Congestive heart failure and/or coronary artery disease
Blood pressure monitor Hypertension
Inhaled corticosteroids Asthma
Insulin and other glucose lowering agents Diabetes
Retinopathy screening Diabetes
Peak flow meter Asthma
Glucometer Diabetes
Hemoglobin A1c testing Diabetes
International Normalized Ratio (INR) testing Liver disease and/or bleeding disorders
Low-density Lipoprotein (LDL) testing Heart disease
Selective Serotonin Reuptake Inhibitors (SSRIs) Depression
Statins Heart disease and/or diabetes

Source: IRS Notice 2019-45

 

Katie Ripp

Get in on the conversation.

Unfortunately, we cannot give free advice to non-clients by email, comment response, or phone call. Thank you! Read our disclaimer.